A Precursor on Pandemic Corona Virus: An Infectious Disease
COVID-19
DOI:
https://doi.org/10.24203/ajas.v8i3.6156Keywords:
Pandemic, corona virus, infectious diseases, respiratory syndrome, treatment, outbreak control, global readinessAbstract
This paper is a study on Corona virus and its effects on human beings in particular and how it has become a global pandemic. The reason for the world’s pandemic, Corona virus is an RNA virus found extensively in mammals including humans. It is found that the most human corona virus infections cause from mild symptoms to severe respiratory problems and lead to death. In the recent past the world has faced two great epidemics caused by two different beta-corona viruses and they were named as SARS-CoV (Severe Acute Respiratory Syndrome Corona Virus) and (MERS-CoV Middle East Respiratory Syndrome Coronavirus). Despite these viruses had high infectivity, had less mortality rate. As it is known, these types of viruses, in general, cause a mild illness and considerably affect children and young adults. As the whole world is facing a pandemic situation today, carrying out research on finding vaccine to kill the virus is a need of the time. It is obvious that to understand the fighting measurements, in other words readiness of the nation in handling the situation, the local risk assessments are considered to be one of the key factors in comprehending COVID-19. It is pathetic to know that this virus spreads rapidly everywhere and considering this fast outbreak, the global wide readiness, building capacity and mutual collaborations among countries are the most important needs in order to control the outbreak.
References
[2]. Lai MT, et al. (2007) Cell growth restoration and high level protein expression by the promoter of hexose transporter, HXT7, from Saccharomyces cerevisiae. Biotechnol Lett vol 29(8), pp: 1287-92
[3]. Xu X, Chen P, Wang J, et al.(2020), Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Life Sciences ; vol 63(3), pp:457-460.
[4]. Guan W, Ni Z, Liang W, et al. Clinical characteristics of coronavirus disease in China. N Engl J Med February 28, 2020; DOI:10.1056/MEJMoa2002032.
[5]. Coronavirus. https://www.webmd.com/lung/coronavirus#1. Published January 22, 2020.
[6]. https://www.aljazeera.com/news/2020/01/coronavirus-symptoms-vaccines-risks-200122194509687.html . Published January 30, 2020
[7]. https://www.marham.pk/all-diseases/coronavirus
[8]. Jacobs, S.E., Lamson, D.M., et al 2013. Human rhi¬noviruses. Clin. Microbiol. Rev. 26, 135–162
[9]. Bella, J., Rossmann, M.G., 2000. ICAM-1 receptors and cold viruses.
Pharm. Acta Helv. 74, 291–297.
[10]. Han, T., Marasco, W.A., 2011. Structural basis of influenza virus neutralization.
Ann. N.Y. Acad. Sci. 1217, 178–190.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Narmathadevi V, Ramya K, Kishore Balasubramanian, Das J
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Papers must be submitted on the understanding that they have not been published elsewhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and are not currently under consideration by another journal published by any other publisher.
- It is also the authors responsibility to ensure that the articles emanating from a particular source are submitted with the necessary approval.
- The authors warrant that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required.
- The authors ensure that all the references carefully and they are accurate in the text as well as in the list of references (and vice versa).
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution-NonCommercial 4.0 International that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.
